Basal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy
The DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index.
Abstract
Interferon (IFN)-alpha is a cytokine of the innate immune response that is well known for inducing behavioral alterations and has been used to study effects of cytokines on the nervous system. Limited data, however, are available on the sites of action of IFN-alpha within the brain and their relationship with specific IFN-alpha-induced symptoms. Using a longitudinal design, whole-brain metabolic activity as assessed by fluorine-18-labeled fluorodeoxyglucose uptake and positron emission tomography was examined before and 4 weeks after IFN-alpha administration in patients with malignant melanoma. Changes in metabolic activity in relevant brain regions were then correlated with IFN-alpha-induced behavioral changes. IFN-alpha administration was associated with widespread bilateral increases in glucose metabolism in subcortical regions including the basal ganglia and cerebellum. Decreases in dorsal prefrontal cortex glucose metabolism were also observed. Prominent IFN-alpha-induced behavioral changes included lassitude, inability to feel, and fatigue. Correlational analyses revealed that self-reported fatigue (specifically as assessed by the 'energy' subscale of the Visual Analog Scale of Fatigue) was associated with increased glucose metabolism in the left nucleus accumbens and putamen. These data indicate that IFN-alpha as well as other cytokines of the innate immune response may target basal ganglia nuclei, thereby contributing to fatigue-related symptoms in medically ill patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IFNα administration was found to be associated with increased glucose metabolism in the basal ganglia and cerebellum, which are involved in motor activity and motivation”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Capuron et al., 2007
In the citing paper
“the observed NDI increase has been interpreted as representing the inflammatory process.”
From NODDI in clinical research (2020) · cites this paper as Capuron et al., 2007
In the citing paper
“In agreement with this, cancer patients treated with IFN-α display decreased glucose metabolism in the dorsal prefrontal cortex but increased glucose metabolism in the cerebellum and basal ganglia73.”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [73]
In the citing paper
“IFN-α therapy led to reports of fatigue in a sample of patients with malignant melanoma that were positively correlated with increased glucose metabolism in the basal ganglia (the left putamen and left NAc) (Capuron et al., 2007).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Capuron et al., 2007
In the citing paper
“IFN-α therapy led to reports of fatigue in a sample of patients with malignant melanoma that were positively correlated with increased glucose metabolism in the basal ganglia (the left putamen and left NAc) (Capuron et al., 2007).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Capuron et al., 2007
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages
Cox, R. W. (1996) · Computers and Biomedical Research · doi:10.1006/cbmr.1996.0014 · Cited by 10,913
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527 · cited 1×
“Given the role of dopamine pathways in activating frontal cortex neurons (Alexander et al, 1986), altered basal ganglia and dopamine function may also contribute to the reduced metabolic activity observed in the frontal cortex following IFN-a administration.”
BackgroundForman, S. D., Cohen, J. D., Fitzgerald, M., Eddy, W. F., Mintun, M. A., & Noll, D. C. (1995) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910330508 · Cited by 3,202
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Self-citationThe Mini-Mental State Examination
Folstein, M. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790060110016 · Cited by 1,936
Cited by
Items 201–229 of 229
From syndromes to symptoms: Advancing our understanding of mental disorders
Clack, S. (2020) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17151110.v1 · Cited by 4
Utility of 18F FDG PET/CT in Hemophagocytic Lymphohistiocytosis
Aggarwal, P., Tyagi, L., Singh, H., Kumar, R., Singh, H., Prakash, G., Jindal, A. K., Sachdeva, M. S., Suri, D., & Mittal, B. R. (2025) · Indian Journal of Nuclear Medicine · doi:10.4103/ijnm.ijnm_5_25 · Cited by 2
Montet, J., Montalban, E., Dexpert, S., Magne, E., Beau, C., Forestier, D., Ledaguenel, P., Gostner, J. M., Fuchs, D., Aouizerate, B., et al. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106547 · Cited by 3
Self-citationFloris, G., Zanda, M. T., Dabrowski, K. R., & Daws, S. E. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03203-4 · Cited by 3
Some Unresolved Issues for the Study of Fatigue: The Way Forward
Gerber, L. H. (2010) · PM&R · doi:10.1016/j.pmrj.2010.03.032 · Cited by 2
Aripiprazole‑induced akathisia associated with bilateral putaminal hypermetabolism on PET
Meda, N., Lussignoli, M., Gugliotta, A. A., Cecchin, D., Pigato, G., & Sambataro, F. (2026) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000626 · Cited by 1
Neuroimaging and Clinical Studies on Brain–Immune Interactions
Hannestad, J. O. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_4 · Cited by 1
Inflammation, Interferon-Alpha, and Depression
Lotrich, F. E. (2012) · Psychiatric Annals · doi:10.3928/00485713-20120906-04 · Cited by 1
Brain morphometry and chronic inflammation in Bangladeshi children growing up in extreme poverty
Turesky, T. K., Pirazzoli, L., Shama, T., Hafiz, S., Haque, R., Islam, N., Someshwar, A., Gagoski, B. A., Petri, W. A., Nelson, C. A., et al. (2024) · Imaging Neuroscience · doi:10.1162/imag_a_00319 · Cited by 1
“Previous work has identified links between inflammation and brain structure and function ( B ø et al., 2003; Capuron et al., 2007, 2012; Duggan et al., 2001; Fisher et al., 2008; Gianaros et al., 2013; Goldstein et al., 2021; Graham et al., 2018; Hansen-Pupp et al., 2005; Jefferson et al., 2007;…”
BackgroundMethodInfluentialMeyer, P. T., Gobbelé, R., Ludolph, A., Schaefer, W. M., Waberski, T.-D., & Schiel, M. (2009) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3181abb655 · Cited by 1
PET Imaging in Psychoneuroimmunology Research
Hannestad, J. O. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7828-1_15 · Cited by 1
Altered brain diagnostic techniques in obesity and related metabolic complications
Safabakhsh, M., Alipoor, E., & Hosseinzadeh‐Attar, M. J. (2019) · Obesity Medicine · doi:10.1016/j.obmed.2019.100117 · Cited by 1
Depression in cancer: pathophysiology at the mind-body interface
Burke, M. A., Raison, C. L., & Miller, A. H. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511780868.011 · Cited by 2
Self-citationFrom inflammation to sickness and depression: the cytokine connection
Dantzer, R., & Kelley, K. W. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511780868.014 · Cited by 2
Suchacz, M. (2017) · Wydawnictwa Uniwersytetu Warszawskiego eBooks · doi:10.31338/uw.9788323528111.pp.131-136 · Cited by 1
Inflammatory Bases of Neuropsychiatric Symptom Domains: Mechanisms and Specificity
Aouizerate, B., Vancassel, S., Castanon, N., & Capuron, L. (2021) · Springer eBooks · doi:10.1007/978-3-030-71229-7_20 · Cited by 3
Self-citationCurrent awareness: Pharmacoepidemiology and drug safety
(2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1487
Current awareness: Pharmacoepidemiology and drug safety
(2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1368
FROM DEPRESSION TO HUMAN IMMUNODEFICIENCY VIRUS – A CASE REPORT
Sapira, V., Lungu, M., Baciu, A. P., Telehuz, A., Marcu, C., Chiscop, I., Gavrila, C., Dinu, C. A., Baciu, G., & Ciubară, A. (2023) · European Conference of Psychiatry and Mental Health "Galatia" · doi:10.35630/2022/12/psy.ro.19
Sigamani, A., Naik, K. S., & Kumar, S. S. (2023) · Research Square · doi:10.21203/rs.3.rs-2676572/v1 · Cited by 3
Lin, C., Yeh, F.-C. F., Glynn, N. W., Gmelin, T. A., Wei, Y., Chen, Y.-L., Huang, C., Shyu, Y., & Chen, C. (2024) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2024.111793 · Cited by 1
The Role of Technology in Advancing Psychoneuroimmunology Research
Bansal, V., Amruthavarshini, M. S., & Reddy, K. J. (2025) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-7432-0.ch018 · Cited by 1
Ponchel, A. (2016) · theses.fr (ABES) · doi:10.70675/2efa91a7zb34dz4171zb8d6z03624ba9000c
Fanet, H. (2018) · theses.fr (ABES) · doi:10.70675/b46d2065zecc9z4e97zae20zf9e2e4fe0c69 · Cited by 1
Kaluza, L., Kühnel, A., Picón‐Galindo, E., Hergenröther, M., Alkhateeb, H., Michalski, S., Ribeiro, D. J. S., Schmidt, S. V., Wachten, D., & Kroemer, N. B. (2026) · BMC Psychology · doi:10.1186/s40359-026-05219-5
Wu, T., Li, J., Zhao, F., & Liu, Z. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-11151-6
Kaluza, L., Kühnel, A., Kuskova, E., Studener, K., Rommel, D., Lieberz, J., & Kroemer, N. B. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.107002 · Cited by 1
吉田, 英., Kuga, T., Yanagimoto, Y., 中西, 恵., Makiyama, A., Murayama, G., Minowa, K., Kusaoi, M., Yamaji, K., & Tamura, N. (2026) · Lupus Science & Medicine · doi:10.1136/lupus-2026-002234
Metadata
- Authors
- Capuron, L., Pagnoni, G., Demetrashvili, M. F., Lawson, D. H., Fornwalt, F. B., Woolwine, B., Berns, G. S., Nemeroff, C. B., & Miller, A. H.
- Affiliations
- Emory University (US)
- Corresponding author
- Miller, Andrew H
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 2007-02-28
- Volume
- 32
- Issue
- 11
- Pages
- 2384-2392
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2072184805
- Cited by
- 229
- References
- 70
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 7 · 2023: 10 · 2022: 5 · 2021: 9 · 2020: 15 · 2019: 10 · 2018: 17 · 2017: 12 · 2016: 18 · 2015: 17 · 2014: 8 · 2013: 14 · 2012: 22
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion)
- Funders
- Abbott Laboratories
- American Foundation for Suicide Prevention
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- American Psychiatric Institute for Research and Education
- Emory University
- National Alliance for Research on Schizophrenia and Depression
- ACADIA Pharmaceuticals
- Neurocrine Biosciences
- Centers for Disease Control and Prevention
- Pfizer Pharmaceuticals
- National Institute of Mental Health (MH 067990, R01MH067990, MH069124, K05MH069124)
- National Institute on Drug Abuse (K08DA000367, DA-00367)
- National Institute of Biomedical Imaging and Bioengineering (EB002635, R01EB002635)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Keywords
- interferon-alpha, basal ganglia, fatigue, glucose metabolism, nucleus accumbens, putamen, cerebellum, prefrontal cortex, melanoma, lassitude, immune-related adverse events
- MeSH terms
- Adult, Basal Ganglia, Behavioral Symptoms, Brain Mapping, Female, Humans, Immunologic Factors, Longitudinal Studies, Male, Middle Aged, Fatigue Syndrome, Chronic, Interferon-alpha, Radiopharmaceuticals, Fluorodeoxyglucose F18, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.